Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Dent Res ; 90(4): 489-94, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21118795

ABSTRACT

Fluorosed enamel can be porous, mottled, discolored, hypomineralized, and protein-rich if the enamel matrix is not completely removed. Proteolytic processing by matrix metalloproteinase-20 (MMP20) and kallikrein-4 (KLK4) is critical for enamel formation, and homozygous mutation of either protease results in hypomineralized, protein-rich enamel. Herein, we demonstrate that the lysosomal proteinase cathepsin K is expressed in the enamel organ in a developmentally defined manner that suggests a role for cathepsin K in degrading re-absorbed enamel matrix proteins. We therefore asked if fluoride directly inhibits the activity of MMP20, KLK4, dipeptidyl peptidase I (DPPI) (an in vitro activator of KLK4), or cathepsin K. Enzyme kinetics were studied with quenched fluorescent peptides with purified enzyme in the presence of 0-10 mM NaF, and data were fit to Michaelis-Menten curves. Increasing concentrations of known inhibitors showed decreases in enzyme activity. However, concentrations of up to 10 mM NaF had no effect on KLK4, MMP20, DPPI, or cathepsin K activity. Our results show that fluoride does not directly inhibit enamel proteolytic activity.


Subject(s)
Dental Enamel Proteins/drug effects , Dental Enamel/enzymology , Fluorides/pharmacology , Peptide Hydrolases/drug effects , Ameloblasts/drug effects , Amelogenesis/drug effects , Amelogenesis/physiology , Animals , Cathepsin C/analysis , Cathepsin C/drug effects , Cathepsin K/antagonists & inhibitors , Cathepsin K/drug effects , Cysteine Proteinase Inhibitors/pharmacology , Dipeptides/administration & dosage , Dipeptides/pharmacology , Dose-Response Relationship, Drug , Enamel Organ/drug effects , Enzyme Inhibitors/pharmacology , Kallikreins/antagonists & inhibitors , Kallikreins/drug effects , Leucine/analogs & derivatives , Leucine/pharmacology , Matrix Metalloproteinase 20/drug effects , Matrix Metalloproteinase Inhibitors , Protease Inhibitors/administration & dosage , Protease Inhibitors/pharmacology , Serine Proteinase Inhibitors/administration & dosage , Serine Proteinase Inhibitors/pharmacology , Sulfones/administration & dosage , Sulfones/pharmacology , Swine , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...